| Target and Pathway |
Top |
| Target(s) |
B-lymphocyte surface antigen B4 (CD19) |
Target Info
|
CAR-T-Cell-Therapy(Dual specific) |
[1] |
| Interleukin 3 receptor alpha (IL3RA) |
Target Info
|
CAR-T-Cell-Therapy(Dual specific) |
[1] |
|
KEGG Pathway
|
Cytokine-cytokine receptor interaction
|
|
PI3K-Akt signaling pathway
|
|
Apoptosis
|
|
Jak-STAT signaling pathway
|
|
Hematopoietic cell lineage
|
|
B cell receptor signaling pathway
|
|
Epstein-Barr virus infection
|
|
Primary immunodeficiency
|
|
NetPath Pathway
|
IL5 Signaling Pathway
|
|
IL3 Signaling Pathway
|
|
IL-7 Signaling Pathway
|
|
Panther Pathway
|
B cell activation
|
|
Pathway Interaction Database
|
IL3-mediated signaling events
|
|
BCR signaling pathway
|
|
Reactome
|
GPVI-mediated activation cascade
|
|
G beta:gamma signalling through PI3Kgamma
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
RAF/MAP kinase cascade
|
|
Interleukin receptor SHC signaling
|
|
PIP3 activates AKT signaling
|
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
|
Constitutive Signaling by Aberrant PI3K in Cancer
|
|
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
|
WikiPathways
|
IL-3 Signaling Pathway
|
|
Interleukin-2 signaling
|
|
Interleukin-3, 5 and GM-CSF signaling
|
|
Human Complement System
|
|
Signaling by the B Cell Receptor (BCR)
|
|
PIP3 activates AKT signaling
|
|
B Cell Receptor Signaling Pathway
|
|
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
|
